« Back to Record
Citation APA

Lafeuillade, A., Clumeck, N., Mallolas, J., Jaeger, H., Livrozet, J.-M., do Sameira Ferreira, M., Johnson, M., Cheret, A., Antoun, Z., Demonty, J., Bazin, C., Bentata, M., Bouvet, É., Delfraissy, J., Dellamonica, P., Saint Marc, T., De Saint Martin, L., De Truchis, P., Dien, G., Gallais, H., Gil, H., Hoen, B., Katlama, C., Lacoste, D., Lang, J., Beumont, M., Massip, P., Rozenbaum, W., Sereni, D., Yeni, P., Fenske, S., Rockstroh, J., Salzberger, B., Schuermann, D., Staszewski, S., Mulcahy, F., Lazzarin, A., Milazzo, F., Moroni, M., Cargnel, A., Santos, C. P., Flamholc, L., Koppel, K., Easterbrook, P., Fisher, M., Gazzard, B., Kinghorn, G., Weber, J., & Wilkins, E. (2003). Comparison of metabolic abnormalities and clinical lipodystrophy 48 weeks after switching from HAART to Trizivir™ versus continued HAART: The trizal study. HIV clinical trials, 4(1), 37-43. doi:10.1310/EJRF-JGGH-GRCD-MED8


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/84790

Lafeuillade, A., Clumeck, N., Mallolas, J., Jaeger, H., Livrozet, J.-M., do Sameira Ferreira, M., Johnson, M., Cheret, A., Antoun, Z., Demonty, J., Bazin, C., Bentata, M., Bouvet, É., Delfraissy, J., Dellamonica, P., Saint Marc, T., De Saint Martin, L., De Truchis, P., Dien, G., Gallais, H., Gil, H., Hoen, B., Katlama, C., Lacoste, D., Lang, J., Beumont, M., Massip, P., Rozenbaum, W., Sereni, D., Yeni, P., Fenske, S., Rockstroh, J., Salzberger, B., Schuermann, D., Staszewski, S., Mulcahy, F., Lazzarin, A., Milazzo, F., Moroni, M., Cargnel, A., Santos, C. P., Flamholc, L., Koppel, K., Easterbrook, P., Fisher, M., Gazzard, B., Kinghorn, G., Weber, J., & Wilkins, E. (2003). Comparison of metabolic abnormalities and clinical lipodystrophy 48 weeks after switching from HAART to Trizivir™ versus continued HAART: The trizal study. HIV clinical trials, 4(1), 37-43. doi:10.1310/EJRF-JGGH-GRCD-MED8